Alkomex Pharma Private Limited
About Alkomex Pharma Private Limited
Data last updated:
Alkomex Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24303DL2017PTC315829. Its GSTIN is 02AAPCA4345N1ZG (Himachal Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Piyush Mittal and Leena Mittal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 754 Ground Floor Jai Ambey Apartments New Kondli Mayur Vihar – Phase – III, Delhi, India – 110096.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.66 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹2.62 Cr (net margin 11.1%) and EBITDA of ₹4.02 Cr (EBITDA margin 17%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 11% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Alkomex Pharma. As per MCA filings, the company has open charges of ₹23.58 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address754 Ground Floor Jai Ambey Apartments New Kondli Mayur Vihar – Phase – III, Delhi, India – 110096
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Alkomex Pharma Private Limited
The main business activity of Alkomex Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Alkomex Pharma Private Limited FY 2024 filings available
Alkomex Pharma Private Limited reported revenue of ₹23.66 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Alkomex Pharma Private Limited
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Alkomex Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.02 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.62 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Alkomex Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Alkomex Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Alkomex Pharma Private Limited
Alkomex Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Enzyme Engineering & Services Private Limited | ₹23.68 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Ranchi, Jharkhand, India |
| Meenakshi Cement-N-Steel (Bangluru) Private Limited | ₹23.67 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Bangalore, Karnataka, India |
| Pacfo International Private Limited | ₹23.67 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Ballabgarh, Haryana, India |
| Botek India Private Limited | ₹23.66 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Stories Global Homes Private Limited | ₹23.66 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Kozhikode, Kerala, India |
| Alkomex Pharma Private Limited this company | ₹23.66 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Delhi, India |
| Esp Engineered Components Private Limited | ₹23.66 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
| Aegis Infrasolutions (India) Private Limited | ₹23.66 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Navi Mumbai, Maharashtra, India |
| Vridhii Steel Private Limited | ₹23.66 Cr (FY 2024) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Karta Ram Shiv Lal Private Limited | ₹23.65 Cr (FY 2025) | •••• | •••• | 86.0% | •••• | Jaitu, Punjab, India |
| Beri Resources Private Limited | ₹23.65 Cr (FY 2025) | •••• | •••• | 382.0% | •••• | Dhanbad, Jharkhand, India |
Peers are the five companies nearest above and the five nearest below Alkomex Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Alkomex Pharma Private Limited
Alkomex Pharma Private Limited is audited by P T R G & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P T R G & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Alkomex Pharma Private Limited
Alkomex Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Piyush Mittal Also directs: Flurry Foods Private Limited, Zenvita Private Limited, Adira Labs Private Limited and 2 more | Director | 10 Apr 2017 | 9 Years 6 Months | Current |
| Leena Mittal Also directs: N.G. Electro Products Private Limited | Director | 10 Apr 2017 | 9 Years 6 Months | Current |
| Raghav Piyush Mittal Also directs: Flurry Foods Private Limited, Adira Labs Private Limited, N.G. Electro Products Private Limited and 2 more | Director | 18 Feb 2020 | 6 Years 7 Months | Current |
Ownership and Shareholding of Alkomex Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Alkomex Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2024 | Others | ₹15 Cr | Open |
| 21 Sep 2024 | Hdfc Bank Limited | ₹1.68 Cr | Open |
| 25 Jan 2022 | Others | ₹6.9 Cr | Open |
Total charge records: 3 View all charges
Associated Brands with Alkomex Pharma Private Limited
Alkomex Pharma operates one associated brand: ALKOMEX PHARMA. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical company delivering a range of products and services to the industry. | alkomexpharma.com |
Employees and EPFO Compliance at Alkomex Pharma Private Limited
Alkomex Pharma Private Limited has a workforce of 9 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Alkomex Pharma Private Limited
Alkomex Pharma Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Alex Segundo Meneses Vega ceased to be Director on 14 Mar 2023.
Credit Ratings, Litigation & Regulatory Alerts for Alkomex Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Alkomex Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Alkomex Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Alkomex Pharma Private Limited
Alkomex Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAPCA4345N1ZG | Himachal Pradesh | Active | 12 Oct 2017 |
| 09AAPCA4345N1Z2 | Uttar Pradesh | Active | 31 May 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Alkomex Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alkomex Pharma Private Limited
Alkomex Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 April 2017 (9+ years old) and is registered under CIN U24303DL2017PTC315829.
Alkomex Pharma reported revenue of ₹23.66 Cr for FY 2025 (down 12% YoY).
Alkomex Pharma has 3 current directors:
- Piyush Mittal - Director
- Leena Mittal - Director
- Raghav Piyush Mittal - Director
Alkomex Pharma reported a net profit of ₹2.62 Cr (net margin 11.1%) and EBITDA of ₹4.02 Cr (EBITDA margin 17%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Alkomex Pharma is -10% over three years and 11% over five years. In the latest year (FY 2025) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Alkomex Pharma is 02AAPCA4345N1ZG, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAPCA4345N1Z2 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Alkomex Pharma is U24303DL2017PTC315829. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alkomex Pharma was incorporated on 10 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Alkomex Pharma by revenue are Enzyme Engineering & Services Private Limited, Meenakshi Cement-N-Steel (Bangluru) Private Limited, Pacfo International Private Limited, Botek India Private Limited, Stories Global Homes Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Alex Segundo Meneses Vega ceased to be Director on 14 Mar 2023. Raghav Piyush Mittal was appointed as Director on 18 Feb 2020. Leena Mittal was appointed as Director on 10 Apr 2017. Alkomex Pharma has 4 board changes on record in total.
The registered office of Alkomex Pharma is at 754 Ground Floor Jai Ambey Apartments New Kondli Mayur Vihar – Phase – III, Delhi, India – 110096.